IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

This big near term arbitrage here is the valuation disparity...

  1. MickeyMantle536
    933 Posts.
    lightbulb Created with Sketch. 1446
    clock Created with Sketch.
    13/09/21
    20:50
    Post #: 56032550
    This big near term arbitrage here is the valuation disparity between IHL and their US listed peers (Compass, GW Pharma, MindMed and CARA for example).

    Each of these would represent a material improvement on the current Aussie valuation of IHL.

    Then add even one clinical success and IMO it’s game over, GW Pharma style…
    IHL Price at posting: 39.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 29  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.